Insider Selling: Aflac Incorporated (NYSE:AFL) Director Sells 1,000 Shares of Stock

Aflac Incorporated (NYSE:AFL) Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Aflac Price Performance

NYSE:AFL opened at $104.67 on Thursday. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50. The firm has a market cap of $57.21 billion, a price-to-earnings ratio of 10.90, a P/E/G ratio of 3.24 and a beta of 0.93. The firm’s 50-day simple moving average is $105.24 and its 200 day simple moving average is $107.70. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10.

Aflac (NYSE:AFL) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, sell-side analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Hedge Funds Weigh In On Aflac

Several hedge funds have recently bought and sold shares of the company. Private Trust Co. NA increased its holdings in Aflac by 1.3% in the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock valued at $791,000 after buying an additional 99 shares during the period. Phillips Wealth Planners LLC increased its holdings in Aflac by 1.5% in the 4th quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock valued at $662,000 after buying an additional 100 shares during the period. Raleigh Capital Management Inc. increased its holdings in Aflac by 23.2% in the 4th quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after buying an additional 100 shares during the period. TKG Advisors LLC increased its holdings in Aflac by 0.5% in the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock valued at $2,230,000 after buying an additional 103 shares during the period. Finally, Covestor Ltd increased its holdings in Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after buying an additional 107 shares during the period. 67.44% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on AFL shares. Barclays cut their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, February 7th. Piper Sandler cut their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Wells Fargo & Company cut their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Finally, Evercore ISI cut their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Aflac has an average rating of “Hold” and a consensus price target of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.